Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1997 Apr;71(4):2772–2778. doi: 10.1128/jvi.71.4.2772-2778.1997

Genetically engineered live attenuated influenza A virus vaccine candidates.

N T Parkin 1, P Chiu 1, K Coelingh 1
PMCID: PMC191400  PMID: 9060631

Abstract

We have generated new influenza A virus live attenuated vaccine candidates by site-directed mutagenesis and reverse genetics. By mutating specific amino acids in the PB2 polymerase subunit, two temperature-sensitive (ts) attenuated viruses were obtained. Both candidates have 38 degrees C shutoff temperatures in MDCK cells, are attenuated in the respiratory tracts of mice and ferrets, and have very low reactogenicity in ferrets. Infection of mice or ferrets with either mutant conferred significant protection from challenge with the homologous wild-type virus. Three tests for genetic stability were used to assess the propensity for reversion to virulence: 14 days of replication in nude mice, growth at 37 degrees C in tissue culture, and serial passage in ferrets. One candidate, which contains mutations intended to reduce the ability of PB2 to bind to cap structures, was stable in all three assays, whereas the second candidate, which contains mutations found only in other ts strains of influenza virus, lost its ts phenotype in the last two assays. This approach has therefore enabled the creation of live attenuated influenza A virus vaccine candidates suitable for human testing.

Full Text

The Full Text of this article is available as a PDF (90.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altmann M., Edery I., Trachsel H., Sonenberg N. Site-directed mutagenesis of the tryptophan residues in yeast eukaryotic initiation factor 4E. Effects on cap binding activity. J Biol Chem. 1988 Nov 25;263(33):17229–17232. [PubMed] [Google Scholar]
  2. Biswas S. K., Nayak D. P. Influenza virus polymerase basic protein 1 interacts with influenza virus polymerase basic protein 2 at multiple sites. J Virol. 1996 Oct;70(10):6716–6722. doi: 10.1128/jvi.70.10.6716-6722.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Braam J., Ulmanen I., Krug R. M. Molecular model of a eucaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription. Cell. 1983 Sep;34(2):609–618. doi: 10.1016/0092-8674(83)90393-8. [DOI] [PubMed] [Google Scholar]
  4. Clements M. L., Subbarao E. K., Fries L. F., Karron R. A., London W. T., Murphy B. R. Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers. J Clin Microbiol. 1992 Mar;30(3):655–662. doi: 10.1128/jcm.30.3.655-662.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cox N. J., Kitame F., Kendal A. P., Maassab H. F., Naeve C. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology. 1988 Dec;167(2):554–567. [PubMed] [Google Scholar]
  6. Detjen B. M., St Angelo C., Katze M. G., Krug R. M. The three influenza virus polymerase (P) proteins not associated with viral nucleocapsids in the infected cell are in the form of a complex. J Virol. 1987 Jan;61(1):16–22. doi: 10.1128/jvi.61.1.16-22.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fazekas G., Rosenwirth B., Dukor P., Gergely J., Rajnavölgyi E. IgG isotype distribution of local and systemic immune responses induced by influenza virus infection. Eur J Immunol. 1994 Dec;24(12):3063–3067. doi: 10.1002/eji.1830241222. [DOI] [PubMed] [Google Scholar]
  8. Fedson D. S. Influenza and pneumococcal vaccination of the elderly: newer vaccines and prospects for clinical benefits at the margin. Prev Med. 1994 Sep;23(5):751–755. doi: 10.1006/pmed.1994.1129. [DOI] [PubMed] [Google Scholar]
  9. Foster D. A., Talsma A., Furumoto-Dawson A., Ohmit S. E., Margulies J. R., Arden N. H., Monto A. S. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol. 1992 Aug 1;136(3):296–307. doi: 10.1093/oxfordjournals.aje.a116495. [DOI] [PubMed] [Google Scholar]
  10. Glezen W. P., Payne A. A., Snyder D. N., Downs T. D. Mortality and influenza. J Infect Dis. 1982 Sep;146(3):313–321. doi: 10.1093/infdis/146.3.313. [DOI] [PubMed] [Google Scholar]
  11. Glezen W. P. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 1982;4:25–44. doi: 10.1093/oxfordjournals.epirev.a036250. [DOI] [PubMed] [Google Scholar]
  12. Gorse G. J., Belshe R. B. Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults. J Clin Microbiol. 1990 Nov;28(11):2539–2550. doi: 10.1128/jcm.28.11.2539-2550.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gorse G. J., Belshe R. B., Munn N. J. Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines. J Clin Microbiol. 1988 May;26(5):911–918. doi: 10.1128/jcm.26.5.911-918.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gorse G. J., Belshe R. B., Munn N. J. Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults. Chest. 1991 Oct;100(4):977–984. doi: 10.1378/chest.100.4.977. [DOI] [PubMed] [Google Scholar]
  15. Gorse G. J., Otto E. E., Powers D. C., Chambers G. W., Eickhoff C. S., Newman F. K. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. J Infect Dis. 1996 Feb;173(2):285–290. doi: 10.1093/infdis/173.2.285. [DOI] [PubMed] [Google Scholar]
  16. Govaert T. M., Thijs C. T., Masurel N., Sprenger M. J., Dinant G. J., Knottnerus J. A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994 Dec 7;272(21):1661–1665. [PubMed] [Google Scholar]
  17. Herlocher M. L., Maassab H. F., Webster R. G. Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6032–6036. doi: 10.1073/pnas.90.13.6032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ishida T., Katsuta M., Inoue M., Yamagata Y., Tomita K. The stacking interactions in 7-methylguanine-tryptophan systems, a model study for the interaction between the 'cap' structure of mRNA and its binding protein. Biochem Biophys Res Commun. 1983 Sep 30;115(3):849–854. doi: 10.1016/s0006-291x(83)80012-6. [DOI] [PubMed] [Google Scholar]
  19. Lawson C. M., Subbarao E. K., Murphy B. R. Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus. Virology. 1992 Nov;191(1):506–510. doi: 10.1016/0042-6822(92)90221-a. [DOI] [PubMed] [Google Scholar]
  20. Maassab H. F., Kendal A. P., Abrams G. D., Monto A. S. Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J Infect Dis. 1982 Dec;146(6):780–790. doi: 10.1093/infdis/146.6.780. [DOI] [PubMed] [Google Scholar]
  21. Maassab H. F. THE PROPAGATION OF MULTIPLE VIRUSES IN CHICK KIDNEY CULTURES. Proc Natl Acad Sci U S A. 1959 Jul;45(7):1035–1039. doi: 10.1073/pnas.45.7.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Massicot J. G., Murphy B. R., Thierry F., Markoff L., Huang K. Y., Chanock R. M. Temperature-sensitive mutants of influenza virus. Identification of the loci of the two ts lesions in the Udorn-ts-1A2 donor virus and the correlation of the presence of these two ts lesions with a predictable level of attenuation. Virology. 1980 Feb;101(1):242–249. doi: 10.1016/0042-6822(80)90499-7. [DOI] [PubMed] [Google Scholar]
  23. Massicot J. G., Murphy B. R., van Wyke K., Huang K. Y., Chanock R. M. ts P1 and P3 genes are responsible for satisfactory level of attenuation of ts-1A2 recombinants bearing H1N1 or H3N2 surface antigens of influenza A virus. Virology. 1980 Oct 15;106(1):187–190. doi: 10.1016/0042-6822(80)90241-x. [DOI] [PubMed] [Google Scholar]
  24. McCauley J. W., Penn C. R. The critical cut-off temperature of avian influenza viruses. Virus Res. 1990 Nov;17(3):191–198. doi: 10.1016/0168-1702(90)90064-i. [DOI] [PubMed] [Google Scholar]
  25. Mukaigawa J., Nayak D. P. Two signals mediate nuclear localization of influenza virus (A/WSN/33) polymerase basic protein 2. J Virol. 1991 Jan;65(1):245–253. doi: 10.1128/jvi.65.1.245-253.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Murphy B. R., Markoff L. J., Chanock R. M., Spring S. B., Maassab H. F., Kendal A. P., Cox N. J., Levine M. M., Douglas R. G., Jr, Betts R. F. Genetic approaches to attenuation of influenza A viruses for man. Philos Trans R Soc Lond B Biol Sci. 1980 Feb 25;288(1029):401–415. doi: 10.1098/rstb.1980.0017. [DOI] [PubMed] [Google Scholar]
  27. Murphy B. R., Markoff L. J., Hosier N. T., Massicot J. G., Chanock R. M. Production and level of genetic stability of an influenza A virus temperature-sensitive mutant containing two genes with ts mutations. Infect Immun. 1982 Jul;37(1):235–242. doi: 10.1128/iai.37.1.235-242.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Murphy B. R., Tolpin M. D., Massicot J. G., Kim H. Y., Parrott R. H., Chanock R. M. Escape of a highly defective influenza A virus mutant from its temperature sensitive phenotype by extragenic suppression and other types of mutation. Ann N Y Acad Sci. 1980;354:172–182. doi: 10.1111/j.1749-6632.1980.tb27966.x. [DOI] [PubMed] [Google Scholar]
  29. Nichol K. L., Margolis K. L., Wuorenma J., Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994 Sep 22;331(12):778–784. doi: 10.1056/NEJM199409223311206. [DOI] [PubMed] [Google Scholar]
  30. Parkin N. T., Chiu P., Coelingh K. L. Temperature sensitive mutants of influenza A virus generated by reverse genetics and clustered charged to alanine mutagenesis. Virus Res. 1996 Dec;46(1-2):31–44. doi: 10.1016/s0168-1702(96)01373-1. [DOI] [PubMed] [Google Scholar]
  31. Patriarca P. A., Weber J. A., Parker R. A., Hall W. N., Kendal A. P., Bregman D. J., Schonberger L. B. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA. 1985 Feb 22;253(8):1136–1139. [PubMed] [Google Scholar]
  32. Plotch S. J., Bouloy M., Ulmanen I., Krug R. M. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell. 1981 Mar;23(3):847–858. doi: 10.1016/0092-8674(81)90449-9. [DOI] [PubMed] [Google Scholar]
  33. Powers D. C., Fries L. F., Murphy B. R., Thumar B., Clements M. L. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory. J Clin Microbiol. 1991 Mar;29(3):498–505. doi: 10.1128/jcm.29.3.498-505.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Powers D. C., Murphy B. R., Fries L. F., Adler W. H., Clements M. L. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies. J Am Geriatr Soc. 1992 Feb;40(2):163–167. doi: 10.1111/j.1532-5415.1992.tb01938.x. [DOI] [PubMed] [Google Scholar]
  35. Shi L., Summers D. F., Peng Q., Galarz J. M. Influenza A virus RNA polymerase subunit PB2 is the endonuclease which cleaves host cell mRNA and functions only as the trimeric enzyme. Virology. 1995 Apr 1;208(1):38–47. doi: 10.1006/viro.1995.1127. [DOI] [PubMed] [Google Scholar]
  36. Smith H., Sweet C. Lessons for human influenza from pathogenicity studies with ferrets. Rev Infect Dis. 1988 Jan-Feb;10(1):56–75. doi: 10.1093/clinids/10.1.56. [DOI] [PubMed] [Google Scholar]
  37. Snyder M. H., Betts R. F., DeBorde D., Tierney E. L., Clements M. L., Herrington D., Sears S. D., Dolin R., Maassab H. F., Murphy B. R. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol. 1988 Feb;62(2):488–495. doi: 10.1128/jvi.62.2.488-495.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. St Angelo C., Smith G. E., Summers M. D., Krug R. M. Two of the three influenza viral polymerase proteins expressed by using baculovirus vectors form a complex in insect cells. J Virol. 1987 Feb;61(2):361–365. doi: 10.1128/jvi.61.2.361-365.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Subbarao E. K., Kawaoka Y., Murphy B. R. Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation. J Virol. 1993 Dec;67(12):7223–7228. doi: 10.1128/jvi.67.12.7223-7228.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Subbarao E. K., Park E. J., Lawson C. M., Chen A. Y., Murphy B. R. Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine. J Virol. 1995 Oct;69(10):5969–5977. doi: 10.1128/jvi.69.10.5969-5977.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Tolpin M. D., Clements M. L., Levine M. M., Black R. E., Saah A. J., Anthony W. C., Cisneros L., Chanock R. M., Murphy B. R. Evaluation of a phenotypic revertant of the A/Alaska/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant viruses. Infect Immun. 1982 May;36(2):645–650. doi: 10.1128/iai.36.2.645-650.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tolpin M. D., Massicot J. G., Mullinix M. G., Kim H. W., Parrott R. H., Chanock R. M., Murphy B. R. Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo. Virology. 1981 Jul 30;112(2):505–517. doi: 10.1016/0042-6822(81)90298-1. [DOI] [PubMed] [Google Scholar]
  43. Treanor J., Perkins M., Battaglia R., Murphy B. R. Evaluation of the genetic stability of the temperature-sensitive PB2 gene mutation of the influenza A/Ann Arbor/6/60 cold-adapted vaccine virus. J Virol. 1994 Dec;68(12):7684–7688. doi: 10.1128/jvi.68.12.7684-7688.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Ulmanen I., Broni B. A., Krug R. M. Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7355–7359. doi: 10.1073/pnas.78.12.7355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wright P. F., Sell S. H., Shinozaki T., Thompson J., Karzon D. T. Safety and antigenicity of influenza A/Hong Kong/68-ts-1 (E) (H3N2). J Pediatr. 1975 Dec;87(6 Pt 2):1109–1116. doi: 10.1016/s0022-3476(75)80123-5. [DOI] [PubMed] [Google Scholar]
  46. Yamanaka K., Ogasawara N., Ueda M., Yoshikawa H., Ishihama A., Nagata K. Characterization of a temperature-sensitive mutant in the RNA polymerase PB2 subunit gene of influenza A/WSN/33 virus. Arch Virol. 1990;114(1-2):65–73. doi: 10.1007/BF01311012. [DOI] [PubMed] [Google Scholar]
  47. de la Luna S., Martínez C., Ortín J. Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains. Virus Res. 1989 Jun;13(2):143–155. doi: 10.1016/0168-1702(89)90012-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES